Rafael Solana Lara-rekin lankidetzan egindako argitalpenak (9)

2016

  1. Editorial: NK cell-based cancer immunotherapy

    Frontiers in Immunology

2002

  1. Inhibition of CD28-mediated natural cytotoxicity by KIR2DL2 does not require p56lck in the NK cell line YT-Indy

    Molecular Immunology, Vol. 38, Núm. 7, pp. 495-503

  2. Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells

    Molecular Immunology, Vol. 38, Núm. 9, pp. 637-660

1999

  1. CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor

    Immunology, Vol. 97, Núm. 1, pp. 159-165

  2. NK phenotypic markers and IL2 response in NK cells from elderly people

    Experimental Gerontology, Vol. 34, Núm. 2, pp. 253-265

1995

  1. Calcitriol effect on natural killer cells from hemodialyzed and normal subjects

    Calcified Tissue International, Vol. 56, Núm. 2, pp. 113-117

1994

  1. Downregulation of Fcγ receptor IIIAα (CD16-II) on natural killer cells induced by anti-CD16 mAb is independent of protein tyrosine kinases and protein kinase C

    Cellular Immunology, Vol. 158, Núm. 1, pp. 208-217

1993

  1. RECONOCIMIENTO DE CELULAS NK: IMPLICACION DE LAS MOLECULAS DE HISTOCOMPATIBILIDAD

    Inmunologia, Vol. 12, Núm. 4, pp. 110-117

  2. Regulation of CD69 expression on human natural killer cells: differential involvement of protein kinase C and protein tyrosine kinases

    European Journal of Immunology, Vol. 23, Núm. 5, pp. 1039-1043